Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

CNO Financial executive sells over $72,000 in company stock

Published 04/02/2024, 05:27 PM

CNO Financial Group, Inc. (NYSE:CNO) President of Worksite Division, Karen DeToro, has sold 2,666 shares of company stock for a total value exceeding $72,000, according to a recent SEC filing. The sale took place on April 2, 2024, with the shares being sold at a price of $27.12 each.

The transaction was executed under a Rule 10b5-1 trading plan, which was adopted on December 20, 2023. Rule 10b5-1 trading plans allow company insiders to set up a predetermined plan to sell company stocks, which is designed to prevent any accusations of insider trading. The plan provides a defense against insider trading allegations by demonstrating that the trades were planned ahead of time and not based on material non-public information.

Following the sale, DeToro's remaining stake in CNO Financial Group consists of 72,383 shares of common stock. The sale and the remaining ownership stake are recorded in the non-derivative section of the SEC filing, indicating direct ownership of the shares.

CNO Financial Group, headquartered in Carmel, Indiana, is a holding company for a group of insurance companies operating throughout the United States, and is known for its products and services that help protect the health and retirement needs of middle-income Americans.

Investors and analysts closely monitor insider sales as they may provide insights into an executive's perspective on the company's current valuation or future prospects. However, transactions under a trading plan such as Rule 10b5-1 often indicate pre-planned financial management rather than a change in outlook towards the company.

The details of the transaction are publicly available through the SEC's filing system, which provides transparency into the trading activities of company executives and other insiders.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

Amidst the recent insider sale by CNO Financial Group's President of Worksite Division, Karen DeToro, the company's financial stability and shareholder value remain key points of interest for investors. CNO Financial has demonstrated a strong commitment to its shareholders, as evidenced by its consistent dividend payments. According to InvestingPro Tips, CNO Financial has raised its dividend for 12 consecutive years and has maintained dividend payments for 13 consecutive years. This track record suggests a reliable income stream for investors, which is particularly noteworthy in the current economic landscape.

In addition to its dividend reliability, CNO Financial's financial health is underscored by its ability to cover short-term obligations with liquid assets, another point highlighted in InvestingPro Tips. This financial prudence may provide investors with confidence in the company's risk management strategies. Furthermore, analysts predict that the company will remain profitable this year, which is consistent with its performance over the last twelve months.

Delving into the company's financial metrics, InvestingPro Data reveals a market capitalization of $2.92 billion, a Price/Earnings (P/E) ratio of 11.02, and a Price/Book (P/B) ratio of 1.32 as of the last twelve months ending Q4 2023. These figures are particularly relevant as they provide insights into the company's valuation and financial health. The P/E ratio, which is slightly lower when adjusted to 10.57, indicates that the stock may be reasonably valued relative to its earnings. The P/B ratio suggests that the stock is trading at a slight premium above its book value, which might be justified by the company's solid fundamentals.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

For investors seeking a deeper analysis and more InvestingPro Tips, there are additional tips available at https://www.investing.com/pro/CNO. Use coupon code PRONEWS24 to receive an extra 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking further insights to inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.